Hovione
Sara Gonçalves Botto is a highly experienced professional currently serving as a Global PMO Senior Manager at Hovione since November 2019, where responsibilities include managing projects from drug substance and product development to commercialization. With a background as a Senior Project Manager and Project Manager within the PMO department, Sara has demonstrated expertise in project scope management, customer communications, timeline and cost management, as well as team leadership. Prior experience includes serving as a Product Development & Technical Support Supervisor at Recipharm, overseeing quality assurance and compliance projects, and leading production operations. Sara holds an Executive MBA from INDEG-ISCTE and a Master of Science in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon, with ongoing research at the University of Tübingen focused on olanzapine polymorphs stability.
This person is not in any teams
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.